c-MYC-Induced Sebaceous Gland Differentiation Is Controlled by an Androgen Receptor/p53 Axis

被引:59
|
作者
Cottle, Denny L. [1 ]
Kretzschmar, Kai [1 ,5 ]
Schweiger, Pawel J. [4 ]
Quist, Sven R. [2 ,4 ]
Gollnick, Harald P. [2 ]
Natsuga, Ken [3 ,4 ]
Aoyagi, Satoru [3 ]
Watt, Fiona M. [1 ,4 ,5 ]
机构
[1] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst SCI, Cambridge CB2 1QR, England
[2] Otto Von Guericke Univ, Clin Dermatol & Venereol, DE-39120 Magdeburg, Germany
[3] Hokkaido Univ, Sch Med, Dept Dermatol, Sapporo, Hokkaido 0608638, Japan
[4] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst CRI, Cambridge CB2 0RE, England
[5] Kings Coll London, Guys Hosp, Cte Stem Cells & Regenerat Med, London SE1 9RT, England
来源
CELL REPORTS | 2013年 / 3卷 / 02期
基金
英国惠康基金;
关键词
TERMINAL DIFFERENTIATION; SEBOCYTE PROLIFERATION; STEM-CELLS; P53; EXPRESSION; CARCINOMA; GROWTH; GENE; PATHWAYS; PROTEIN;
D O I
10.1016/j.celrep.2013.01.013
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Although the sebaceous gland (SG) plays an important role in skin function, the mechanisms regulating SG differentiation and carcinoma formation are poorly understood. We previously reported that c-MYC overexpression stimulates SG differentiation. We now demonstrate roles for the androgen receptor (AR) and p53. MYC-induced SG differentiation was reduced in mice lacking a functional AR. High levels of MYC triggered a p53-dependent DNA damage response, leading to accumulation of proliferative SG progenitors and inhibition of AR signaling. Conversely, testosterone treatment or p53 deletion activated AR signaling and restored MYC-induced differentiation. Poorly differentiated human sebaceous carcinomas exhibited high p53 and low AR expression. Thus, the consequences of overactivating MYC in the SG depend on whether AR or p53 is activated, as they form a regulatory axis controlling proliferation and differentiation.
引用
收藏
页码:427 / 441
页数:15
相关论文
共 50 条
  • [31] Cell cycle basis for the onset and progression of c-Myc-induced, TGFα-enhanced mouse mammary gland carcinogenesis
    Dezhong J Liao
    Geraldine Natarajan
    Sandra L Deming
    M Hunter Jamerson
    Michael Johnson
    Gloria Chepko
    Robert B Dickson
    Oncogene, 2000, 19 : 1307 - 1317
  • [32] p53 mediates apoptosis induced by c-Myc activation in hypoxic or gamma irradiated fibroblasts
    Rupnow, BA
    Alarcon, RM
    Giaccia, AJ
    Knox, SJ
    CELL DEATH AND DIFFERENTIATION, 1998, 5 (02): : 141 - 147
  • [33] Role of genomic instability and p53 in AID-induced c-myc–Igh translocations
    Almudena R. Ramiro
    Mila Jankovic
    Elsa Callen
    Simone Difilippantonio
    Hua-Tang Chen
    Kevin M. McBride
    Thomas R. Eisenreich
    Junjie Chen
    Ross A. Dickins
    Scott W. Lowe
    Andre Nussenzweig
    Michel C. Nussenzweig
    Nature, 2006, 440 : 105 - 109
  • [34] The role of p53 in c-myc induced lymphomagenesis mediated by the IgH 3' enhancers.
    Wang, JH
    Boxer, LM
    BLOOD, 2005, 106 (11) : 734A - 734A
  • [35] SEARCH FOR ACCUMULATION OF P53 PROTEIN AND DETECTION OF HUMAN PAPILLOMAVIRUS GENOMES IN SEBACEOUS GLAND CARCINOMA OF THE EYELID
    HAYASHI, N
    FURIHATA, M
    OHTSUKI, Y
    UENO, H
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1994, 424 (05): : 503 - 509
  • [36] c-erbB2 receptor and P53 protein expression in canine mammary gland carcinoma
    Rezaie A.
    Tavasoli A.
    Mehrazma M.
    Bahonar A.
    Comparative Clinical Pathology, 2012, 21 (6) : 1633 - 1636
  • [37] P53 AND ANDROGEN RECEPTOR GENES ANALYSIS IN HUMAN PROSTATE-CANCER
    CASTAGNARO, M
    YANDELL, D
    HIORT, O
    NABER, S
    OLEARY, M
    MEARES, E
    WOLFE, H
    LABORATORY INVESTIGATION, 1993, 68 (01) : A57 - A57
  • [38] Inhibition of p53 expression modifies the specificity of chromatin binding by the androgen receptor
    Guseva, Natalya V.
    Rokhlin, Oskar W.
    Bair, Thomas B.
    Glover, Rebecca B.
    Cohen, Michael B.
    ONCOTARGET, 2012, 3 (02) : 183 - 194
  • [39] C-myc and p53 alterations in development and progression of urothelial tumors
    SchmitzDrager, BJ
    vanRoeyen, CRC
    Gerharz, CD
    Decken, K
    Bultel, H
    Schulz, WA
    Grimm, MO
    Ebert, T
    Ackermann, R
    AKTUELLE UROLOGIE, 1996, 27 (02) : 55 - 60
  • [40] c-myc, p53 and bcl-2 in uveal melanoma
    Chana, JS
    Wilson, GD
    Alexander, RA
    Myatt, N
    Neale, M
    Foss, AJE
    Hungerford, JL
    Cree, IA
    JOURNAL OF PATHOLOGY, 1998, 184 : 33A - 33A